FDA Inspection 1093550 — Baxalta Belgium Manufacturing SA

Baxalta Belgium Manufacturing SA — FEI 3002806503

The FDA completed an inspection of Baxalta Belgium Manufacturing SA on May 31, 2019 in Lessines. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 31, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lessines (Belgium)